🔎 Trials Near Me

홈 › 난소암 › 뉴저지

뉴저지의 난소암 임상 시험

난소암 관련 연구 40개가 뉴저지 내 여러 지역에서 참여자를 모집하고 있습니다.

뉴저지의 도시

공식 연구 텍스트(영어)

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, New Brunswick
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Hunterdon Medical Center, Flemington
  • Monmouth Medical Center Southern Campus, Lakewood
  • Cooperman Barnabas Medical Center, Livingston
  • 외 6개
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05564377

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • John Theurer Cancer Center /ID# 275756, Hackensack
  • Rutgers Cancer Institute of New Jersey /ID# 274358, New Brunswick
  • Holy Name Medical Center /ID# 276240, Teaneck
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT06890338

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • John Theurer Cancer Center at Hackensack UMC, Hackensack
피험자 모집 중1상
19세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06586957

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, East Brunswick
피험자 모집 중2상
18세 ~ 130세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05489211

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • Md Anderson Cancer Center At Cooper /ID# 278390, Camden
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07059845

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Maimonides Medical Center, Short Hills
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 15. 업데이트됨 · NCT07214779

A Study of Isoquercetin in People With Ovarian Cancer

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07303894

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack
피험자 모집 중2상
18세 ~ 99세 · 여성 · 2026. 9. 15. 업데이트됨 · NCT07023627

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Astera Cancer Care, East Brunswick
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  • START New Jersey East Brunswick, East Brunswick
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06303505

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • START - New Jersey, East Brunswick
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0081), Hackensack
  • Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT06824467

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

  • Start Njeb, East Brunswick
피험자 모집 중1/2상
18세 이상 · 여성 · 2026. 9. 1. 업데이트됨 · NCT07736937

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • The John Theruer Cancer Center at Hackensack University Medical Center, Hackensack
피험자 모집 중1상
15세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06276491

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06774963

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
  • 외 1개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07001748

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Hackensack
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07182149

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  • John Theurer Cancer Center, Hackensack
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04895709

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Cooper Hospital University Medical Center, Camden
  • Jersey City Medical Center, Jersey City
  • 외 12개
피험자 모집 중
35세 ~ 50세 · 여성 · 2026. 8. 7. 업데이트됨 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Summit Medical Group, Berkeley Heights
  • Cooper Hospital University Medical Center, Camden
  • 외 9개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06580314

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  • Hackensack University Medical Center - John Theurer Cancer Center, Hackensack
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT05579366

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START New Jersey, East Brunswick
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06270706

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Valley Health System, Paramus
  • Holy Name, Teaneck
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT06161025

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Overlook Medical Center, Summit
피험자 모집 중2상
8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Valley Health System, Paramus
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 2. 업데이트됨 · NCT06819007

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
피험자 모집 중
18세 이상 · 여성 · 2026. 7. 1. 업데이트됨 · NCT05429970

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

  • GSK Investigational Site, Morristown
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 24. 업데이트됨 · NCT04641247

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

  • Carol G. Simon Cancer Center / Atlantic Health, Morristown
피험자 모집 중건강한 지원자 환영
50세 ~ 74세 · 여성 · 2026. 5. 6. 업데이트됨 · NCT00539162

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

  • Holy Name Medical Center, Teaneck
피험자 모집 중3상
18세 이상 · 여성 · 2026. 4. 16. 업데이트됨 · NCT05659381

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 1. 업데이트됨 · NCT06290193

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Hackensack University Medical Center, Hackensack
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 11. 업데이트됨 · NCT06623396

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

  • John Theurer Cancer Center Hackensack University Medical Center, Hackensack
피험자 모집 중1상
18세 이상 · 여성 · 2026. 2. 3. 업데이트됨 · NCT06469281

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  • Rutgers Cancer Institute, New Brunswick
피험자 모집 중2상
18세 이상 · 여성 · 2025. 12. 23. 업데이트됨 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Brunswick
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

  • Exelixis Clinical Site #9, New Brunswick
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 5. 업데이트됨 · NCT05932862

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.